Bacterial Vaccines Discovery and Early Development ▲ Sign in to save

• ▲ Marc J. M. Bonten

  Biochemistry, Genetics and Molecular Biology
  63.2k

  citations

  122

  h-index

  1

  Aachen papers
• ▲ Peter W. M. Hermans

  Utrecht University · University Medical Center Utrecht Medicine
  19.3k

  citations

  69

  h-index

  4

  Aachen papers
• ▲ JAN T. POOLMAN

  Johnson & Johnson (Netherlands) Immunology and Microbiology
  15.3k

  citations

  67

  h-index

  33

  Aachen papers
• ▲ Sergey R. Konstantinov

  Janssen (Netherlands) Biochemistry, Genetics and Molecular Biology
  3.69k

  citations

  27

  h-index

  1

  Aachen papers
• ▲ Jeroen Geurtsen

  Sanofi (Netherlands) · Janssen (Netherlands) Biochemistry, Genetics and Molecular Biology
  3.61k

  citations

  25

  h-index

  42

  Aachen papers
• ▲ Chakkumkal Anish

  AstraZeneca (United States) · Janssen (Netherlands) Chemistry
  1.67k

  citations

  24

  h-index

  9

  Aachen papers
• ▲ Germie van den Dobbelsteen

  Johnson & Johnson (United States) Immunology and Microbiology
  1.3k

  citations

  19

  h-index

  8

  Aachen papers
• ▲ Suzanne P. M. Welten

  Johnson & Johnson (Netherlands) Immunology and Microbiology
  1.22k

  citations

  22

  h-index

  2

  Aachen papers
• ▲ Peter Burghout

  Janssen (Netherlands) · Johnson & Johnson (Netherlands) Biochemistry, Genetics and Molecular Biology
  1.21k

  citations

  19

  h-index

  2

  Aachen papers
• ▲ Viktoria Dotz

  Janssen (Netherlands) Biochemistry, Genetics and Molecular Biology
  1.16k

  citations

  18

  h-index

  12

  Aachen papers
• ▲ Michel Beurret

  Janssen (Netherlands) Chemistry
  866

  citations

  14

  h-index

  8

  Aachen papers
• ▲ Miranda M. C. van Beers

  Johnson & Johnson (Netherlands) Biochemistry, Genetics and Molecular Biology
  835

  citations

  12

  h-index

  1

  Aachen papers
• ▲ Jan Grijpstra

  Janssen (Netherlands) · Johnson & Johnson (Netherlands) Immunology and Microbiology
  812

  citations

  12

  h-index

  3

  Aachen papers
• ▲ Eveline M. Weerdenburg

  Janssen (Netherlands) Medicine
  811

  citations

  8

  h-index

  1

  Aachen papers
• ▲ Oliver Koeberling

  Immunology and Microbiology
  760

  citations

  14

  h-index

  1

  Aachen papers
• ▲ Pauline M.L. Rood

  Janssen (Netherlands) Medicine
  418

  citations

  8

  h-index

  1

  Aachen papers
• ▲ Tracey Day

  Janssen (Netherlands) Immunology and Microbiology
  224

  citations

  5

  h-index

  1

  Aachen papers
• ▲ Alan B. Moran

  Janssen (Netherlands) Biochemistry, Genetics and Molecular Biology
  129

  citations

  6

  h-index

  12

  Aachen papers

18 results

• Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review

  2020 Clinical Infectious Diseases review Biochemistry, Genetics and Molecular Biology Escherichia coli research studies cited by 2 patents

  341

  citations
• Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines

  2021 npj Vaccines article Chemistry Carbohydrate Chemistry and Synthesis Open access cited by 1 patent

  60

  citations
• Epidemiology, Clinical Features, and Antimicrobial Resistance of InvasiveEscherichia ColiDisease in Patients Admitted in Tertiary Care Hospitals

  2023 Open Forum Infectious Diseases article Medicine Sepsis Diagnosis and Treatment Open access

  32

  citations
• Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study

  2023 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  29

  citations
• A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI

  2024 npj Vaccines article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  19

  citations
• A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease

  2024 Journal of Antimicrobial Chemotherapy article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  17

  citations
• A SpA+LukAB vaccine targeting Staphylococcus aureus evasion factors restricts infection in two minipig infection models

  2025 npj Vaccines article Medicine Antimicrobial Resistance in Staphylococcus Open access

  15

  citations
• Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study

  2024 Infection article Medicine Sepsis Diagnosis and Treatment Open access

  8

  citations
• Epidemiology of invasive Escherichia coli disease in adults in England, 2013–2017

  2025 Epidemiology and Infection article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  8

  citations
• Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry

  2024 Carbohydrate Polymers article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access

  5

  citations
• The neglected model validation of antimicrobial resistance transmission models – a systematic review

  2025 Antimicrobial Resistance and Infection Control review Immunology and Microbiology Antibiotic Use and Resistance Open access

  3

  citations
• Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study

  2024 European Journal of Clinical Microbiology & Infectious Diseases article Medicine Urinary Tract Infections Management Open access

  3

  citations
• 120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Study

  2022 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  2

  citations
• Impact of community-acquired invasive Escherichia coli disease on mortality and readmissions in elderly patients: a multi-center study in Germany

  2025 BMC Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  1

  citations
• Mass spectrometric analysis of lipid-linked oligosaccharide heterogeneity in genetically modified E. coli used for glycoconjugate bacterial vaccine production

  2025 Carbohydrate Polymers article Chemistry Mass Spectrometry Techniques and Applications Open access

  1

  citations
• 1823. Clinical Profile and Antimicrobial Susceptibility of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Hospitalized Adults Aged ≥60 Years

  2022 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  0

  citations
• 235. Tracking Invasive Extraintestinal Pathogenic Escherichia coli Disease in Older Adults in a Community-Based Clinical Trial Setting

  2022 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  0

  citations
• 2465. O-serotype Distribution of Escherichia coli Causing Invasive Disease in Tertiary Care Hospital Patients

  2023 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  0

  citations
• Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60–85 years in a randomized, double-blind, phase 1 study

  2024 Journal of Infection and Chemotherapy article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access

  0

  citations

19 results